Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

How To Attend BioNTech Q1 2022 Earnings Conference Call

BioNTech (NASDAQ:BNTX) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend BioNTech (BNTX) Conference Call Follow this link to access the live webcast.

Benzinga

Viatris Q1 2022 Earnings Conference Call On May 9, 2022 At 08:30 AM ET

Viatris (NASDAQ:VTRS) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.

Benzinga

Why Amarin Shares Are Plunging After Q1 Earnings

Amarin Corporation plc (NASDAQ: AMRN) shares are plunging after it said it would continue suspending 2022 revenue guidance and Q1 earnings came short of expectations.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Perficient Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q1, Perficient (NASDAQ:PRFT) earned $27.14 million, a 499.16% increase from the preceding quarter. Perficient also posted a total of $222.11 million in sales, a 3.44% increase since Q4.

Benzinga

ExlService Holdings Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q1, ExlService Holdings (NASDAQ:EXLS) earned $36.18 million, a 27.84% increase from the preceding quarter. ExlService Holdings also posted a total of $329.21 million in sales, a 11.41% increase since Q4.

Benzinga

The Shyft Group Earnings Perspective: Return On Capital Employed

Benzinga Pro data, The Shyft Group (NASDAQ:SHYF) reported Q1 sales of $206.88 million. Earnings fell to a loss of $3.85 million, resulting in a 118.71% decrease from last quarter.

Benzinga

Lincoln Electric Holdings Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Lincoln Electric Holdings (NASDAQ:LECO) earned $126.03 million, a 69.37% increase from the preceding quarter.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Altisource Portfolio Earnings Perspective: Return On Capital Employed

Altisource Portfolio (NASDAQ:ASPS) brought in sales totaling $37.76 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 116.95%, resulting in a loss of $12.03 million.

Benzinga

Stericycle's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q1, Stericycle's (NASDAQ:SRCL) reported sales totaled $664.20 million. Despite a 14.02% increase in earnings, the company posted a loss of $14.10 million.

Benzinga

Analysis: Will Roe V. Wade Bring Viewers Back To MSNBC And CNN?

Among the big three cable news networks, Fox Corp.’s (NASDAQ: FOXA) right-leaning Fox News continues to reign in the ratings, leaving its left-leaning rivals, Comcast Corp.’s (NASDAQ: CMCSA

Benzinga

Aurora Cannabis, GrowGen, The Parent Co. And Other Marijuana Operators Announces Earnings Release Dates

Several large cannabis operators announced their earnings release dates and conference calls.

Benzinga

How To Attend Thoughtworks Holding Q1 2022 Earnings Conference Call

Thoughtworks Holding (NASDAQ:TWKS) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend Thoughtworks Holding (TWKS) Conference Call Follow this link to access the live webcast.

Benzinga

Why AMD Shares Are Rising

Advanced Micro Devices, Inc. (NASDAQ: AMD) shares are trading higher by 6.32% to $96.89 during Wednesday’s pre-market session after the company reported better-than-expected first-quarter adjusted EPS and sales results and raised FY22 sales guidance.

Benzinga

Recap: Minerva Neurosciences Q1 Earnings

Minerva Neurosciences (NASDAQ:NERV) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 6 Analyst Ratings Have To Say About Zebra Technologies

Zebra Technologies (NASDAQ:ZBRA) has observed the following analyst ratings within the last quarter:

Benzinga

How Is The Market Feeling About Google?

Alphabet's (NASDAQ:GOOG) short percent of float has fallen 13.56% since its last report. The company recently reported that it has 1.40 million shares sold short, which is 0.51% of all regular shares that are available for trading.

Benzinga

Carlyle Group: Q1 Earnings Insights

Carlyle Group (NASDAQ:CG) reported its Q1 earnings results on Thursday, April 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Analyst Ratings for Sprout Social

Within the last quarter, Sprout Social (NASDAQ:SPT) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 6 Analyst Ratings Have To Say About Freshworks

Analysts have provided the following ratings for Freshworks (NASDAQ:FRSH) within the last quarter:

Benzinga

4 Analysts Have This to Say About AtriCure

Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

10 Analysts Have This to Say About Marqeta

Within the last quarter, Marqeta (NASDAQ:MQ) has observed the following analyst ratings:

Benzinga

Recap: eXp World Holdings Q1 Earnings

eXp World Holdings (NASDAQ:EXPI) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Oncorus Q1 Earnings

Oncorus (NASDAQ:ONCR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

What's Going On With Starbucks Shares Today?

Starbucks Corporation (NASDAQ: SBUX) shares are trading higher by 6.96% to $79.50 during Wednesday’s pre-market session. The company reported better-than-expected second-quarter sales during Tuesday’s after-hours session.

Benzinga

FDA Accepts AstraZeneca's sBLA for Imfinzi (durvalumab) in biliary tract cancer (BTC) with Priority Review

The U.S. Food and Drug Administration (FDA) has accepted AstraZeneca's (NASDAQ: AZN) supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care chemotherapy and granted Priority Review for patients with locally advanced or metastatic biliary tract cancer (BTC).

1 … 637 638 639 640

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Starbucks Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.